Strathmore Capital Advisors Inc. purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,400 shares of the company’s stock, valued at approximately $682,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in MKGAF. Danske Bank A S purchased a new position in Merck KGaA during the second quarter worth approximately $276,535,000. Great Lakes Advisors LLC purchased a new stake in Merck KGaA in the 2nd quarter valued at $183,444,000. Tocqueville Asset Management L.P. purchased a new stake in Merck KGaA in the 2nd quarter valued at $57,546,000. Danica Pension Livsforsikringsaktieselskab acquired a new stake in shares of Merck KGaA in the 2nd quarter worth $25,541,000. Finally, NewEdge Wealth LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter worth $8,340,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Up 4.5%
OTCMKTS MKGAF opened at $167.38 on Thursday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The business’s fifty day simple moving average is $162.50 and its 200-day simple moving average is $148.28. The firm has a market cap of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
